Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manlong Xu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Rheumatology|November 17, 2010
ERAP1 is associated with ankylosing spondylitis in Han ChineseChao Li, Zhiming Lin, Yingying Xie, et al.
Rheumatology International|December 17, 2009
Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patientsZhiming Lin, Jieruo Gu, Peigen He, et al.
International Journal of Rheumatic Diseases|August 18, 2012
Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitisZaiying Hu, Manlong Xu, Qiuxia Li, et al.
Clinical and Experimental Rheumatology|September 21, 2013
Limitations of lumbar spine MRI in the diagnosis of ankylosing spondylitisZaiying Hu, Manlong Xu, Zhiming Lin, et al.
Rheumatology (Oxford, England)|March 29, 2011
The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in ChinaManlong Xu, Zhiming Lin, Xinghe Deng, et al.
Biomed Research International|August 15, 2015
Predictive Factors of Clinical Response of Infliximab Therapy in Active Nonradiographic Axial Spondyloarthritis PatientsZhiming Lin, Zetao Liao, Jianlin Huang, et al.
Nature Genetics|December 6, 2011
A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitisZhiming Lin, Jin-Xin Bei, Meixin Shen, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Rheumatology|November 17, 2010
ERAP1 is associated with ankylosing spondylitis in Han ChineseChao Li, Zhiming Lin, Yingying Xie, et al.
Rheumatology International|December 17, 2009
Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patientsZhiming Lin, Jieruo Gu, Peigen He, et al.
International Journal of Rheumatic Diseases|August 18, 2012
Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitisZaiying Hu, Manlong Xu, Qiuxia Li, et al.
Clinical and Experimental Rheumatology|September 21, 2013
Limitations of lumbar spine MRI in the diagnosis of ankylosing spondylitisZaiying Hu, Manlong Xu, Zhiming Lin, et al.
Rheumatology (Oxford, England)|March 29, 2011
The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in ChinaManlong Xu, Zhiming Lin, Xinghe Deng, et al.
Biomed Research International|August 15, 2015
Predictive Factors of Clinical Response of Infliximab Therapy in Active Nonradiographic Axial Spondyloarthritis PatientsZhiming Lin, Zetao Liao, Jianlin Huang, et al.
Nature Genetics|December 6, 2011
A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitisZhiming Lin, Jin-Xin Bei, Meixin Shen, et al.
Pageof 2